Sandra J Pavey
Overview
Explore the profile of Sandra J Pavey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savarimuthu Francis S, Larsen J, Pavey S, Duhig E, Clarke B, Bowman R, et al.
PLoS One
. 2011 Mar;
6(3):e17442.
PMID: 21423603
Chronic obstructive pulmonary disease (COPD) is a major public health problem with increasing prevalence worldwide. The primary aim of this study was to identify genes and gene ontologies associated with...
2.
Savarimuthu Francis S, Larsen J, Pavey S, Bowman R, Hayward N, Fong K, et al.
Respir Res
. 2009 Sep;
10:81.
PMID: 19723343
Chronic obstructive pulmonary disease (COPD) is a major public health problem. The aim of this study was to identify genes involved in emphysema severity in COPD patients.Gene expression profiling was...
3.
Mason S, Cozzi S, Pierce C, Pavey S, Parsons P, Boyle G
Invest New Drugs
. 2009 Jul;
28(5):575-86.
PMID: 19636513
We previously identified the induction of senescence in melanoma cell lines sensitive to diterpene esters, indicating a therapeutic potential. Here we compared the cytostatic effects of two diterpene esters: the...
4.
Smith E, De Young N, Pavey S, Hayward N, Nancarrow D, Whiteman D, et al.
Mol Cancer
. 2008 Oct;
7:75.
PMID: 18831746
Background: Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithelium in the esophagus, as a result of reflux. It is the major risk factor for the development...
5.
Larsen J, Pavey S, Passmore L, Bowman R, Hayward N, Fong K
Clin Cancer Res
. 2007 May;
13(10):2946-54.
PMID: 17504995
Purpose: Improving outcomes for early-stage lung cancer is a major research focus at present because a significant proportion of stage I patients develop recurrent disease within 5 years of curative-intent...
6.
Packer L, Pavey S, Boyle G, Stark M, Ayub A, Rizos H, et al.
Int J Cancer
. 2007 Apr;
121(4):784-90.
PMID: 17450523
p14ARF is inactivated by deletions/mutations in many cancer types and can suppress cell growth by both p53-dependent and p53-independent mechanisms. To identify novel downstream effectors of p14ARF, we used gene...